Company Profile of Ya'an Sanjiu Pharmaceutical Co., Ltd.

The company currently has more than 460 employees, including 70 with college degrees and more than 60 with intermediate and senior technical titles, including more than 20 licensed pharmacists.

The company currently has 13 varieties of traditional Chinese medicine injections and dozens of varieties of proprietary Chinese medicines. 3. Six injection varieties, including Shenmai, Shenfu, and Safflower, can be used for intravenous injection, with various specifications of 2ml, 5ml, 10ml, 20ml, 50ml, and 100ml. The large Chinese medicine injection variety system has obtained 22 patents. Shenfu injection and lipid-adjusting tablets have obtained invention patents. The lipid-adjusting tablets are national Class III new drugs. Currently, there are 3 nationally protected traditional Chinese medicine varieties and 3 essential varieties for emergency treatment in TCM hospitals across the country. It is the manufacturer with the most nationally protected traditional Chinese medicine varieties and the list of essential Chinese patent medicines.

The company's traditional Chinese medicine injection production line passed the national GMP certification in 2000. In order to further expand the production scale and improve product quality, a new comprehensive preparation workshop was built in 2003. The new workshop includes oral solid production lines, oral liquid preparation production lines, large-volume injection production lines, small-volume injection production lines, and a freeze-drying production line is reserved. In 2004, the new workshop was built and passed the national GMP certification. The company's annual production capacity can reach 300 million small-volume injections, 8 million bottles of large-volume injections, 500 million tablets, 200 million capsules, 200 tons of granules, 20 tons of pills, 3 million bottles of syrups, and 6 million oral liquids. branch.

In accordance with the requirements of GAP, the company has specially established Ya'an Sanjiu Chinese Medicinal Materials Technology Industrialization Co., Ltd. The company's main business scope includes research and development of Chinese medicinal materials planting, processing, storage, transportation and operation of Chinese medicinal materials, and production of slices. wait. Its slice workshop was built in 2003 and passed the GMP on-site inspection in June 2004. The company has successively established seven authentic medicinal materials technology demonstration areas and production bases for Ophiopogon japonicus, Houttuynia cordata, ginseng, salvia miltiorrhiza, aconite, Achyranthes bidentata and Sichuan safflower. Among them, the Houttuynia cordata base passed the national GAP certification at the end of 2003, becoming the first company in the country and the first in Sichuan to pass the GAP certification; in October 2004, the Ophiopogon japonicus base passed the national GAP certification.